Affinity Pharmaceuticals Private Limited
About Affinity Pharmaceuticals Private Limited
Data last updated:
Affinity Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 06 July 2010.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC069327. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹6 Lakh and a paid-up capital of ₹5.4 Lakh. It was led by directors Manoj Goel and Satyanarayana Reddy Vadde.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at # 1 – 4 – 27/72/132 First Floor Padmashali Colony Kavadiguda, Hyderabad, Telangana, India – 500080.
As per the financials filed for FY 2017, the company reported a revenue of ₹1.19 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹7.81 Lakh (net margin 6.6%) and EBITDA of ₹14.37 Lakh (EBITDA margin 12.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address# 1 – 4 – 27/72/132 First Floor Padmashali Colony Kavadiguda, Hyderabad, Telangana, India – 500080
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Affinity Pharmaceuticals Private Limited
The main business activity of Affinity Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Affinity Pharmaceuticals Private Limited FY 2017 filings available
Affinity Pharmaceuticals Private Limited reported revenue of ₹1.19 Cr (down 3% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR) of Affinity Pharmaceuticals Private Limited
Revenue fell 3% in the latest year. EBITDA fell 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Affinity Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | ₹1.19 Cr | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹14.37 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.81 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Affinity Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 12.1% | •••• | •••• |
| Net Profit Margin | 6.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Affinity Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| E M Pharmaceuticals Private Limited | ₹1.2 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Nissor Pharmaceuticals Limited | ₹1.2 Cr (FY 2025) | •••• | •••• | -52.0% | •••• | Mumbai, Maharashtra, India |
| Healthmate Pharmaceuticals Private Limited | ₹1.2 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Lucknow, Uttar Pradesh, India |
| Livkon Pharmaceuticals Private Limited | ₹1.19 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Ambernath, Maharashtra, India |
| Admaris Pharmaceuticals Private Limited | ₹1.19 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Lucknow, Uttar Pradesh, India |
| Affinity Pharmaceuticals Private Limited this company | ₹1.19 Cr (FY 2017) | •••• | •••• | -3.0% | •••• | Hyderabad, Telangana, India |
| Akhet Pharmaceuticals Private Limited | ₹1.19 Cr (FY 2024) | •••• | •••• | 63.0% | •••• | Jagadhri, Haryana, India |
| Nutshell Pharmaceuticals Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Siwan, Bihar, India |
| Audhataam Pharmaceuticals Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Kiwi Pharmaceuticals Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Mumbai, Maharashtra, India |
| Boxham Organics Pharmaceuticals Private Limited | ₹1.18 Cr (FY 2024) | •••• | •••• | 192.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Affinity Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals Private Limited is audited by SWAMINATHAN B & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SWAMINATHAN B & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Goel Also directs: Affluential Pharmaceuticals Private Limited | Director | 06 Jul 2010 | 16 Years 3 Months | As last reported |
| Satyanarayana Reddy Vadde Also directs: Clarida Pharma Private Limited | Director | 06 Jul 2010 | 16 Years 3 Months | As last reported |
Ownership and Shareholding of Affinity Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Affinity Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Affinity Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2010PTC069327. The current CIN is U24232TG2010PTC069327, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC069327 | Current |
| U24232AP2010PTC069327 | Previous |
Recent Activity on Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Manoj Goel was appointed as Director on 06 Jul 2010.
Credit Ratings, Litigation & Regulatory Alerts for Affinity Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Affinity Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Affinity Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Affinity Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Affinity Pharmaceuticals Private Limited
Affinity Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Affinity Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 06 July 2010 and is registered under CIN U24232TG2010PTC069327. The company has been struck off by the Registrar of Companies and is no longer operational.
Affinity Pharmaceuticals had 2 directors:
- Manoj Goel - Director
- Satyanarayana Reddy Vadde - Director
The CIN (Corporate Identification Number) of Affinity Pharmaceuticals is U24232TG2010PTC069327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Affinity Pharmaceuticals is at # 1 – 4 – 2772132 First Floor Padmashali Colony Kavadiguda, Hyderabad, Telangana, India – 500080.
Affinity Pharmaceuticals was incorporated on 06 July 2010. It is registered with the Registrar of Companies, Hyderabad.
Affinity Pharmaceuticals reported revenue of ₹1.19 Cr for FY 2017 (down 3% YoY).
Affinity Pharmaceuticals has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹5.4 Lakh.
Affinity Pharmaceuticals reported a net profit of ₹7.81 Lakh (net margin 6.6%) and EBITDA of ₹14.37 Lakh (EBITDA margin 12.1%) for FY 2017, as per its filed financial statements.
No. Affinity Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Affinity Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.